For information only. Not investment advice, a recommendation, an offer or a solicitation, and without regard to any recipient’s objectives or circumstances. Figures come from third-party sources believed reliable but not guaranteed, and market data may be delayed. Past performance is not a reliable indicator of future results. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() The Travelers Companies Inc.TRV US · Financials · USD Current price$388.12as of Nov 19, 2026 Summary
Analyst consensusStrong Buy 1Buy 5Hold 17Sell 4Strong Sell 224 analysts 3-year price (USD)Factor profileMulti-factor score 95 / 100 Market data
Business descriptionThe Travelers Companies is a leading U.S. commercial and personal lines property-casualty insurer operating through Business Insurance, Bond & Specialty Insurance, and Personal Insurance. Business Insurance is the core: USD 22.7B of 2025 net written premiums spanning commercial multi-peril (26%), commercial auto (18%), general liability (16%), commercial property (16%), and workers' compensation (15%), plus 9% international and other. The group recently completed the sale of most of its Canadian personal and commercial lines operations. Competitive moatTravelers' edge is underwriting discipline in "long-tail" liability lines — workers' compensation, general liability, commercial multi-peril — where reserving skill compounds over years and is difficult to replicate. H1 2026 delivered USD 781M of pretax favourable prior-year reserve development (versus USD 546M a year earlier) across every segment, evidence of conservative initial reserving. The 2025 combined ratio of 89.9% (loss ratio 61.4% + expense ratio 28.5%) improved from 92.5% in 2024, and the underlying combined ratio improved to 83.9% from 86.2%. That consistency, plus a 28.5% expense ratio held flat through the cycle, underpins a 1.28% dividend and steady buybacks. Recent developments
Investment risks / red flags
Financials
Classification
|
Theme Exposure
Factor Profile (Spider Chart)
TBI ModelPrice Chart (TradingView)
Symbol: TRVBusiness description
The Travelers Companies is a leading U.S. commercial and personal lines property-casualty insurer operating through Business Insurance, Bond & Specialty Insurance, and Personal Insurance. Business Insurance is the core: USD 22.7B of 2025 net written premiums spanning commercial multi-peril (26%), commercial auto (18%), general liability (16%), commercial property (16%), and workers' compensation (15%), plus 9% international and other. The group recently completed the sale of most of its Canadian personal and commercial lines operations.
Competitive moat
Travelers' edge is underwriting discipline in "long-tail" liability lines — workers' compensation, general liability, commercial multi-peril — where reserving skill compounds over years and is difficult to replicate. H1 2026 delivered USD 781M of pretax favourable prior-year reserve development (versus USD 546M a year earlier) across every segment, evidence of conservative initial reserving. The 2025 combined ratio of 89.9% (loss ratio 61.4% + expense ratio 28.5%) improved from 92.5% in 2024, and the underlying combined ratio improved to 83.9% from 86.2%. That consistency, plus a 28.5% expense ratio held flat through the cycle, underpins a 1.28% dividend and steady buybacks.
Recent developments
- Q3 2026 update (CFRA 11/17/2026): 9M catastrophe losses fell 50% to USD 1.4B (vs USD 2.8B); pretax favourable prior-year development USD 966M (vs USD 562M); reported combined ratio 86.3% (vs 93.2%), underlying 84.5% (vs 84.4%). Target lifted to USD 410 but Hold maintained on valuation (~13x FY27E vs 11x 1-yr avg, 12x peers).
- Canada exit closed (Jan 2026): Majority of Canadian personal/commercial lines sold to Definity for ~USD 2.4B (~1.8x book); ~USD 700M earmarked for buybacks, accretive from 2026.
- Street is cautious: 5 Buy / 1 Buy-Hold / 17 Hold / 2 Hold-Sell / 4 Sell; consensus FY27 EPS USD 31.11 (-15% vs FY26 USD 36.80). Evercore cut PT to USD 342 (10/28/2026) while Roth raised to USD 460.
- Thematic: referenced in CFRA's AI & P&C Insurance thematic (11/17/2026).
Investment risks / red flags
- Decelerating premium growth with commercial and auto pricing softening after several years of strong rate.
- Economic sensitivity of commercial lines — weakening demand would hit exposure units on top of rate deceleration.
- Long-tail reserve volatility: adverse prior-year development in workers' comp or general liability would reverse the current favourable trend.
- Catastrophe exposure remains a swing factor; the 2025 California wildfires showed how a single event can dominate a quarter.
- The stock trades above CFRA's 12-month target, i.e. limited implied upside (about -2%).
Market Data
Source: mkts.io · Nov 19, 2026, 18:00 UTC
Key Metrics
Analyst Consensus
Calendar Events
Financials
Forward Estimates
| Period | EPS Est | Rev Est |
|---|---|---|
| 0q | 9.92 | $11.01B |
| +1q | 7.84 | $10.97B |
| 0y | 36.80 | $43.51B |
| +1y | 31.11 | $44.40B |
Earnings
Rating Changes
| Date | Firm | Action | To |
|---|---|---|---|
| Oct 26, 2026 | Cantor Fitzgerald | main | Overweight |
| Oct 23, 2026 | Morgan Stanley | main | Underweight |
| Oct 20, 2026 | BMO Capital | main | Market Perform |
| Oct 20, 2026 | JP Morgan | main | Neutral |
| Oct 20, 2026 | Mizuho | main | Neutral |
| Oct 20, 2026 | Keefe, Bruyette & Woods | main | Market Perform |
